Harmony Biosciences Holdings, Inc. (HRMY)
38.51
+0.36
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
38.51
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Price to Book Value : 2.240 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.219 |
| August 20, 2026 | 2.214 |
| August 19, 2026 | 2.322 |
| August 18, 2026 | 2.258 |
| August 17, 2026 | 2.218 |
| August 14, 2026 | 2.217 |
| August 13, 2026 | 2.239 |
| August 12, 2026 | 2.313 |
| August 11, 2026 | 2.299 |
| August 10, 2026 | 2.268 |
| August 07, 2026 | 2.234 |
| August 06, 2026 | 2.254 |
| August 05, 2026 | 2.224 |
| August 04, 2026 | 2.256 |
| August 03, 2026 | 2.071 |
| July 31, 2026 | 2.050 |
| July 30, 2026 | 2.086 |
| July 29, 2026 | 2.086 |
| July 28, 2026 | 2.081 |
| July 27, 2026 | 2.094 |
| July 24, 2026 | 2.054 |
| July 23, 2026 | 2.082 |
| July 22, 2026 | 2.028 |
| July 21, 2026 | 2.143 |
| July 20, 2026 | 1.948 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.964 |
| July 16, 2026 | 1.950 |
| July 15, 2026 | 2.030 |
| July 14, 2026 | 2.025 |
| July 13, 2026 | 2.067 |
| July 10, 2026 | 2.143 |
| July 09, 2026 | 2.222 |
| July 08, 2026 | 2.215 |
| July 07, 2026 | 2.225 |
| July 06, 2026 | 2.153 |
| July 02, 2026 | 2.167 |
| July 01, 2026 | 2.094 |
| June 30, 2026 | 2.118 |
| June 29, 2026 | 2.246 |
| June 26, 2026 | 2.255 |
| June 25, 2026 | 2.170 |
| June 24, 2026 | 2.190 |
| June 23, 2026 | 2.171 |
| June 22, 2026 | 2.125 |
| June 18, 2026 | 2.116 |
| June 17, 2026 | 2.147 |
| June 16, 2026 | 2.150 |
| June 15, 2026 | 2.173 |
| June 12, 2026 | 2.190 |
| June 11, 2026 | 2.238 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 32.09 |
| Repligen Corp. | 4.854 |
| Johnson & Johnson | 7.739 |
| ACADIA Pharmaceuticals, Inc. | 3.903 |
| ANI Pharmaceuticals, Inc. | 2.856 |
Price to Book Value Related Metrics
| PE Ratio | 12.48 |
| PS Ratio | 2.356 |
| Price to Free Cash Flow | 6.739 |
| Price | 38.51 |
| Earnings Yield | 8.01% |
| Market Cap | 2.238B |
| Operating PE Ratio | 9.807 |
| Normalized PE Ratio | 12.48 |